SK Life Science, Inc. uses modern cloud solution
to accelerate validation processes for increased inspection
readiness
PLEASANTON, Calif., Jan. 11,
2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)
today announced that SK Life Science, Inc., a subsidiary of SK
Biopharmaceuticals Co. Ltd., a global biotech company, is using
Veeva Vault Validation Management to streamline and accelerate
their validation process. By adopting a validation solution with
built-in best practices, the company can execute digital validation
while centralizing data and improving visibility.
SK Life Science builds off its success with
Veeva Vault QualityDocs and Vault QMS to optimize validation
management.
"As the industry continues to shift from traditional paper-based
validation, more companies are advancing validation with Veeva
Vault Validation Management to streamline and standardize
processes," said Nina Ricciardelli,
director, Veeva Vault Validation Management. "SK Life Science, Inc.
is a prime example of one of those forward-thinking companies
modernizing validation for greater efficiency and speed."
SK Life Science, Inc., an innovative pharmaceutical company
committed to accelerating the development of next-generation
treatments for central nervous system (CNS) disorders and cancer
care, adopted Vault Validation Management to further support its
team with digital collaboration, standardized processes and
workflows, and simpler test execution. The company is building off
its success with Veeva Vault QualityDocs and Veeva Vault QMS to
optimize its validation programs, driving greater compliance and
traceability across all systems. Shifting to a digital approach
provides the transparency necessary to identify trends and
proactively address potential issues, reducing compliance
risks.
"Veeva Vault Validation Management allows us to further simplify
our validation process for significant cost and time-savings in
test execution," said Hina Patel,
vice president and global head of quality assurance, SK Life
Science, Inc. "Using an advanced validation solution helps improve
our efficiency, data integrity, and audit readiness."
Additional Information
For more on Veeva Vault Validation Management, visit:
veeva.com/VaultValidationManagement
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life
sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 1,000 customers, ranging
from the world's largest biopharmaceutical companies to emerging
biotechs. As a Public Benefit Corporation, Veeva is committed to
balancing the interests of all stakeholders, including customers,
employees, shareholders, and the industries it serves. For more
information, visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding
Veeva's products and services and the expected results or benefits
from use of our products and services. These statements are based
on our current expectations. Actual results could differ materially
from those provided in this release and we have no obligation to
update such statements. There are numerous risks that have the
potential to negatively impact our results, including the risks and
uncertainties disclosed in our filing on Form 10-Q for the period
ended October 31, 2023, which you can
find here (a summary of risks which may impact our business can be
found on pages 38 and 39), and in our subsequent SEC filings, which
you can access at sec.gov.
Contact:
Deivis
Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leading-pharma-adopts-veeva-vault-validation-management-for-digital-validation-execution-and-improved-efficiency-302031709.html
SOURCE Veeva Systems